EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma

Cheng Zhang, Wenjing Wei, Shuo Tu, Bo Liang, Chun Li, Yining Li, Weicheng Luo, Yiqing Wu, Xiaohui Dai, Yi Wang, Lijuan Zheng, Liang Hao und 4 weitere

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Cheng Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medicine, Jiangxi Medical College, Nancha…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cysteine-Rich Protein 61, Gene Expression Regulation, Neoplastic, Liver Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangxi Provincial Natural Science Foundation, Shanghai Jiao Tong University, Zhejiang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor-β (TGF-β) and Hippo signaling are two critical pathways engaged in cancer progression by regulating both oncogenes and tumor suppressors, yet how the two pathways coordinately exert their functions in the development of hepatocellular carcinoma (HCC) remains elusive. In this study, we firstly conducted an integrated analysis of public liver cancer databases and our experimental TGF-β target genes, identifying CYR61 as a pivotal candidate gene relating to HCC development. The expression of CYR61 is downregulated in clinical HCC tissues and cell lines than that in the normal counterparts. Evidence revealed that CYR61 is a direct target gene of TGF-β in liver cancer cells. In addition, TGF-β-stimulated Smad2/3 and the Hippo pathway downstream effectors YAP and TEAD4 can form a protein complex on the promoter of CYR61, thereby activating the promoter activity and stimulating CYR61 gene transcription in a collaborative manner. Functionally, depletion of CYR61 enhanced TGF-β- or YAP-mediated growth and migration of liver cancer cells. Consistently, ectopic expression of CYR61 was capable of impeding TGF-β- or YAP-induced malignant transformation of HCC cells in vitro and attenuating HCC xenograft growth in nude mice. Finally, transcriptomic analysis indicates that CYR61 can elicit an antitumor program in liver cancer cells. Together, these results add new evidence for the crosstalk between TGF-β and Hippo signaling and unveil an important tumor suppressor function of CYR61 in liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCysteine-Rich Protein 61Gene Expression Regulation, NeoplasticLiver NeoplasmsTransforming Growth Factor betaYAP-Signaling ProteinsAnimalsHumansMiceCell Line, TumorCell MovementData MiningHippo Signaling PathwayMice, NudePromoter Regions, GeneticSignal TransductionSmad2 ProteinSmad3 ProteinTEA Domain Transcription FactorsUp-Regulation

Stichwörter der Autor:innen

CYR61TGF-βYAP/TEAD4hepatocellular carcinomasignaling crosstalktranscriptional regulation

Substanzen

CCN1 protein, humanCysteine-Rich Protein 61Smad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTEA Domain Transcription FactorsTEAD4 protein, humanTransforming Growth Factor betaYAP-Signaling Proteins

Autor:innen und Institutionen

  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medicine, Jiangxi Medical College, Nanchang University, Nanchang, China; The First Affiliated Hospital, Jiangxi…
  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medicine, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, China.

Förderung

  • Jiangxi Provincial Natural Science Foundation
  • Shanghai Jiao Tong University
  • Zhejiang University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, C., Wei, W., Tu, S., Liang, B., Li, C., Li, Y., Luo, W., Wu, Y., Dai, X., Wang, Y., Zheng, L., Hao, L., Zhang, C., Luo, Z., Chen, Y. G., & Yan, X. (2024). Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107208

Vancouver

Zhang C, Wei W, Tu S, Liang B, Li C, Li Y, et al. Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107208

BibTeX
@article{Zhang2024,
  author = {Zhang, Cheng and Wei, Wenjing and Tu, Shuo and Liang, Bo and Li, Chun and Li, Yining and Luo, Weicheng and Wu, Yiqing and Dai, Xiaohui and Wang, Yi and Zheng, Lijuan and Hao, Liang and Zhang, Chunbo and Luo, Zhijun and Chen, Ye-Guang and Yan, Xiaohua},
  title = {Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107208}
}
Kostenlos starten →